Metraipolis › archive › dc_bcd002bf9f41

Nanoparticle-Based Tolerogenic Vaccines: Next-Generation Strategies for Autoimmune and Allergic Disease Therapies — Europe PMC PMID:41451511

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41451511
DOI
10.1002/anie.202524097
License (as archived)
solo-consultazione
Archived
2026-11-07T10:01:57.071Z
SHA-256 of the archived text
200c84c467b42042abde8f17ff3d3ed7cde7b8eb7a981b913925e69fadb67db6
Stable URL of this page
https://metraipolis.com/documento/dc_bcd002bf9f41

How to cite

Nanoparticle-Based Tolerogenic Vaccines: Next-Generation Strategies for Autoimmune and Allergic Disease Therapies — Europe PMC PMID:41451511 — Europe PMC (en), https://europepmc.org/article/MED/41451511 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcd002bf9f41 (Metraipolis archive dc_bcd002bf9f41, sha256 200c84c467b42042abde8f17ff3d3ed7cde7b8eb7a981b913925e69fadb67db6)
BibTeX
@misc{dcbcd002bf9f41,
  title = {Nanoparticle-Based Tolerogenic Vaccines: Next-Generation Strategies for Autoimmune and Allergic Disease Therapies — Europe PMC PMID:41451511},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41451511},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcd002bf9f41; sha256 200c84c467b42042abde8f17ff3d3ed7cde7b8eb7a981b913925e69fadb67db6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41451511. Agents can read the archived copy with the MCP tool read_document.